Related Experiment Video
Updated: Apr 28, 2026

07:56
Formation of Biomembrane Microarrays with a Squeegee-based Assembly Method
Published on: May 8, 2014
12.9K
Facile synthesis of multilayered polysaccharidic vesicles
Dong Sup Kwag1, Kyung Taek Oh2, Eun Seong Lee1
1Department of Biotechnology, The Catholic University of Korea, 43-1 Yeokgok 2-dong, Wonmi-gu, Bucheon, Gyeonggi-do 420-743, Republic of Korea.
Summary
Researchers created multilayered polysaccharidic vesicles (mPSVs) for drug delivery. These vesicles effectively target and inhibit tumors in vivo, showing potential for advanced biomedical applications.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Drug Delivery Systems
Background:
- Polysaccharides offer biocompatibility and biodegradability for advanced drug carriers.
- Developing efficient drug delivery systems is crucial for targeted therapy and reduced side effects.
Purpose of the Study:
- To develop facile synthesis methods for multilayered polysaccharidic vesicles (mPSVs).
- To investigate the potential of mPSVs for targeted drug delivery and tumor inhibition.
Main Methods:
- Synthesized mPSVs using polysaccharides like starch, hyaluronate (HA), and glycol chitosan (GC) via simple chemistry and enzymatic reactions.
- Utilized enzymatic degradation of the HA shell by hyaluronidase (HYAL) to control drug release.
- Incorporated folate ligand and D-(KLAKLAK)2 peptide for active targeting and apoptosis induction.
Main Results:
- Enzymatic degradation of the HA shell accelerated protein/peptide release from mPSVs.
- mPSVs demonstrated effective accumulation in KB tumor cells through passive targeting (EPR effect) and active targeting (folate receptor binding).
- Significant increase in in vivo tumor inhibition was observed with the mPSV system.
Conclusions:
- The developed mPSVs represent a promising platform for biomedical applications.
- This vesicle system shows potential for delivering small molecular drugs targeting proteins and genes.
- The facile synthesis and targeted delivery capabilities highlight the advancement in polysaccharide-based drug delivery technology.
Related Concept Videos
Biosynthesis of Polysaccharides
983
Polysaccharides such as glycogen and starch are synthesized from nucleoside diphosphate sugars, primarily uridine diphosphate glucose (UDPG) and adenosine diphosphate glucose (ADPG). These activated glucose donors act as key intermediates in carbohydrate metabolism and biosynthesis. UDPG primarily involves glycogen synthesis in animals and many bacteria, while ADPG plays a fundamental role in starch synthesis in plants and certain bacteria.UDPG is formed when glucose-1-phosphate reacts with...
983
Oligosaccharide Assembly
2.6K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
2.6K
Formation of Lipopolysaccharides
1.1K
Lipopolysaccharides (LPS) are crucial components of the outer membrane of Gram-negative bacteria, serving both structural and functional roles. It contributes to membrane stability and protects bacteria from host immune responses. LPS is composed of three major regions—lipid A, a core oligosaccharide, and an O antigen. The biosynthesis and assembly of LPS involve a highly coordinated set of enzymatic reactions and transport mechanisms. Additionally, LPS is recognized as an endotoxin,...
1.1K

